Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European …

P Ljungman, R de la Camara, C Robin… - The Lancet infectious …, 2019 - thelancet.com
Cytomegalovirus is one of the most important infections to occur after allogeneic
haematopoietic stem cell transplantation (HSCT), and an increasing number of reports …

Cytomegalovirus in hematopoietic stem cell transplant recipients

P Ljungman, M Hakki… - Hematology/Oncology …, 2011 - hemonc.theclinics.com
Human cytomegalovirus (CMV) is a betaherpesvirus in the same family as human
herpesvirus-6 and-7. CMV is a large virus including approximately 200 proteins. CMV has …

[HTML][HTML] American Society for Transplantation and Cellular Therapy series:# 3—prevention of cytomegalovirus infection and disease after hematopoietic cell …

M Hakki, SL Aitken, L Danziger-Isakov… - … and Cellular Therapy, 2021 - Elsevier
Abstract The Practice Guidelines Committee of the American Society for Transplantation and
Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group to …

Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation

J Styczynski - Infectious diseases and therapy, 2018 - Springer
Cytomegalovirus (CMV) is an agent of global infection, and its acquisition in a population is
characterized by an age-dependent rise in seropositivity. After primary infection, CMV …

Human cytomegalovirus latency and reactivation in allogeneic hematopoietic stem cell transplant recipients

L Stern, B Withers, S Avdic, D Gottlieb… - Frontiers in …, 2019 - frontiersin.org
Human cytomegalovirus (HCMV) reactivation is a major infectious cause of morbidity and
mortality after allogeneic hematopoietic stem cell transplantation (HSCT). HCMV is a …

Immune reconstitution post allogeneic transplant and the impact of immune recovery on the risk of infection

RS Mehta, K Rezvani - Virulence, 2016 - Taylor & Francis
Infection is the leading cause of non-relapse mortality after allogeneic haematopoietic cell
transplantation (HCT). This occurs as a result of dysfunction to the host immune system from …

[HTML][HTML] Infections after transplantation of bone marrow or peripheral blood stem cells from unrelated donors

JAH Young, BR Logan, J Wu, JR Wingard… - Biology of blood and …, 2016 - Elsevier
Infection is a major complication of hematopoietic cell transplantation. Prolonged
neutropenia and graft-versus-host disease are the 2 major complications with an associated …

Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of …

PJ Hanley, CRY Cruz, B Savoldo… - Blood, The Journal …, 2009 - ashpublications.org
The naive phenotype of cord blood (CB) T cells may reduce graft-versus-host disease after
umbilical cord blood transplantation, but this naivety and their low absolute numbers also …

Pre‐transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation …

B George, N Pati, N Gilroy… - Transplant infectious …, 2010 - Wiley Online Library
B. George, N. Pati, N. Gilroy, M. Ratnamohan, G. Huang, I. Kerridge, M. Hertzberg, D.
Gottlieb, K. Bradstock. Pre‐transplant cytomegalovirus (CMV) serostatus remains the most …

CMV infection in hematopoietic stem cell transplantation: prevention and treatment strategies

N Jakharia, D Howard, DJ Riedel - Current treatment options in infectious …, 2021 - Springer
Abstract Purpose of Review Cytomegalovirus (CMV) remains a major cause of morbidity and
mortality after allogeneic hematopoietic stem cell transplantation (Allo-HSCT). New …